收藏切换
Research progress, chemistry, manufacturing and controls considerations of mesenchymal stem cell products
收藏切换
PDF
Jia-qi LU, Wei WEI, Bo-ning LIU, Jian-hui LUO*
Acta Pharmaceutica Sinica | 2019, 54(7) : 1317 - 1324
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(7): 1317-1324
New Drug Forum
Research progress, chemistry, manufacturing and controls considerations of mesenchymal stem cell products
Full
Jia-qi LU, Wei WEI, Bo-ning LIU, Jian-hui LUO*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
Published: 2019-07-12 doi: 10.16438/j.0513-4870.2019-0135
Outline
收藏切换

The number of clinical trials for mesenchymal stem cell (MSC) products ranked the top among all stem cell products, with more than 900 trials ongoing or completed by 2018. In China, many MSC clinical trials have started as "the third type of medical technique" and the dossiers of MSC products have been submitted to National Medical Products Administration (NMPA). The biological function and therapeutic effect of MSCs are constantly being recognized in scientific communities. However, the observed functions of MSCs in vitro are not fully reproduced in the living microenvironment in vivo. There are substantial variations among tissue origins, cellular phenotypes and biological functions. Different formulations, delivery methods, manufacture processes or doses all greatly affect the clinical efficacy. It is difficult for MSCs to maintain the naive state due to the differences between in vitro culture conditions and in vivo microenvironment. Meanwhile, there is no widely accepted scientific definition for MSCs until now, due to the complexity of manufacturing process and variable sources. Consequently, the regulation of MSC products is a challenge for drug administrative agencies. In this article, we review the research progress of MSC products around the world, and summarize the considerations in evaluating the chemistry, manufacturing and controls (CMC) section of MSC product applications, with respect to raw materials, manufacture processes and quality control. We hope that the information summarized here will provide insights for the development and evaluation of MSC products.

mesenchymal stem cell  /  clinical research  /  manufacture process  /  quality control  /  chemistry, manufacture and control evaluation
Jia-qi LU, Wei WEI, Bo-ning LIU, Jian-hui LUO. Research progress, chemistry, manufacturing and controls considerations of mesenchymal stem cell products[J]. Acta Pharmaceutica Sinica, 2019 , 54 (7) : 1317 -1324 . DOI: 10.16438/j.0513-4870.2019-0135
Year 2019 volume 54 Issue 7
PDF
191
78
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0135
  • Receive Date:2019-02-23
  • Online Date:2026-01-26
  • Published:2019-07-12
Article Data
Affiliations
History
  • Received:2019-02-23
  • Revised:2019-04-22
Affiliations
    Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0135
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT